Cat.#: ACPP-1371
| Despition | Ki67 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1123 | Recombinant Rat GFAP Protein (AC1123) | 25 µl | inquiry |
| ACPP-1747 | Human TSG Protein (AC1747) | 10 µg | inquiry |
| ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg | inquiry |
| ACPP-1731 | Human DNAJC19 Protein (AC1731) | 2 µg | inquiry |
| ACPP-1614 | Human MPPED2 Protein (AC1614) | 2 µg | inquiry |
| ACPP-1820 | Rat CNTF Protein, His (AC1820) | 2 µg | inquiry |
| ACPP-1221 | Bestrophin Blocking Peptide (AC1221) | 250 µg | inquiry |
| ACPP-1021 | Recombinant Human PGP9.5 Protein (Fc Tag) (AC1021) | 50 µg | inquiry |
| ACPP-1042 | Recombinant Human BACE1 Protein (6×His Tag) (AC1042) | 50 µg | inquiry |
| ACPP-1468 | Human MEIS3 Protein (AC1468) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.